Alcyone's ThecaFlex is an implantable medical device under investigation for routine subcutaneous administration of therapeutics to the cerebrospinal fluid (CSF). The first stage of the pivotal ...

The funds will support regulatory activities and the planned 510 (k) submission for approval to the U.S. Food and Drug Administration (FDA) for Flexi-Port ™ SLF-TANL ™, a novel subcutaneous ...

The "port," also known as a subcutaneous port, is an implantable device that allows for treatment to be delivered directly into a vein. Middleton's hospital visit come just days after she revealed ...

Flexi-Port ™ SLF-TANL ™ is currently not available for sale. For more information or to be added to our market launch, please contact: Angela Dotson Executive VP Business Development 540-817-5515 ...